NEW YORK (Reuters Health) - Thirty years after treatment for childhood acute lymphoblastic leukemia, survivors remain at increased risk for developing a second cancer, according to a new report.>>> Discuss This Story
NEW YORK (Reuters Health) - Thirty years after treatment for childhood acute lymphoblastic leukemia, survivors remain at increased risk for developing a second cancer, according to a new report.>>> Discuss This Story
